Where are the disconnects between Patient, Prescriber and Pharma, the Peas? Albert Einstein once said “given one hour to save the world, I would spend 55 minutes defining the problem and 5 minutes finding the solution.” With this quote, Einstein emphasized the critical importance of thoroughly understanding a problem before even thinking about solving it. Investing time in comprehensively defining and analyzing issues that affect our industry is foundational to what Peas in the Pod does. In simpler terms, we just love digging deep into the why of everything. Below we have provided a broad outline of the fundamental disconnects that may exist in relationship between the three Peas. We have identified six of them. 1️⃣Patient Perspective: Often overlooked during early stages of drug development. 2️⃣Prescriber Needs: Potential misalignments between commercial teams' strategies and actual needs of prescribers. 3️⃣Prescriber-Pharma antagonism: Lacking sense of partnership between prescribers and pharmaceutical manufacturers. 4️⃣Prescriber-Patient Interactions: Challenges that lead to patients feeling misunderstood by their healthcare providers. 5️⃣Pricing & Reimbursement: Decisions that may neglect the full impact of disease on patients' lives. 6️⃣Cross-Functional Alignment: Lack of shared vision and understanding of patients and prescribers’ needs within the pharmaceutical company. What have you observed in your experience? Which one of these potential disconnects resonates with you? In our next post, we will start breaking it all down into the potential root causes of these disconnects. ⏭ Stay tuned for more! #pharmamarketing #insights #patientengagement #healthcare #marketresearch #pharma
Peas In the Pod’s Post
More Relevant Posts
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Addressing diversity gaps in #clinicaltrials is crucial for equitable #healthcare outcomes. While recent government guidance is a step forward, pharmaceutical companies must take proactive steps now. Our CEO Ariel Katz predicts three factors that will fuel a massive transformation in clinical trial diversity in his article for Society for Clinical Research Sites (SCRS): https://hubs.la/Q02kRZ_Q0 #clinicaltrials #diversity #pharma
To view or add a comment, sign in
-
-
Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher
To view or add a comment, sign in
-
-
Join this 5-day course and learn to navigate the complex world of Pharmaceutical Market Access: With our expert guidance, understand how to effectively communicate the value of your brands to key payers. Grasp the intricacies of Health Technology Assessment, pricing, and reimbursement in an evolving landscape marked by economic pressures and demographic shifts. Learn to tackle the challenges posed by innovative yet costly drugs and secure market access by mastering cost-effectiveness and containment strategies. Gain clarity on who the real decision-makers are in this competitive field, and discover how market access is not just about budget control but also about bringing tangible benefits to patients and society." #CopenhagenSummerUniversity #lifelonglearning https://lnkd.in/djFysSC5
To view or add a comment, sign in
-
At Simon-Kucher our experts specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our insights on a better market access and navigate the intricate trade-offs of price 💰, access 🗝️, and time ⏲️ to ensure optimal market penetration and rapid reimbursement. skp.link/xr1 #BetterMarketAccess #Pharma #Strategy #Healthcare #SimonKucher
To view or add a comment, sign in
-
-
Plan sponsors face the complex challenge of managing the high costs of innovative medications while ensuring appropriate treatments for employees. Groundbreaking drugs, ranging from disease cures to obesity management, often come with high costs, sometimes in the millions. By integrating pharmacy and medical claims data, plan sponsors can gain a comprehensive view of their spending. This enables them to anticipate new drug impacts, minimize member disruptions, and optimize budget management and affordability. To demonstrate the important role of integrated data, click below to explore some of the challenges that plan sponsors face and how using pharmacy and medical claims data can provide invaluable solutions. Download the playbook for a more detailed example of each clinical topic. #EPICinsurancebrokers #EPICBenefits #PSG Managing Pharmacy Costs with Integrated Data | Pharmaceutical Strategies Group (PSG) (psgconsults.com)
Pharmaceutical Strategies Group (PSG)
psgconsults.com
To view or add a comment, sign in